secwatch.observer — SEC 8-K summary
======================================

Issuer:     TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
CIK:        0000818686
Form:       8-K
Filed at:   2021-07-21T23:59:59+00:00
Accession:  0001157523-21-000890
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teva announces executive reshuffle; North America Commercial head replaced, two promotions
--------------------------------------------------------------------------------

- Brendan O'Grady, EVP North America Commercial, resigns effective Aug 15, 2021 to pursue outside opportunity.
- Sven Dethlefs appointed as new head of North America Commercial, from EVP Global Marketing and International Markets.
- Mark Sabag moves to EVP International Markets Commercial; Galia Inbar becomes EVP Chief HR Officer.
- Eli Shani promoted to EVP Global Marketing and Portfolio. All changes effective Aug 15, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818686/000115752321000890/0001157523-21-000890-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818686/000115752321000890/a52463594.htm
  HTML page:      https://secwatch.observer/filing/0001157523-21-000890

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer